Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) - Barrington Research lowered their Q3 2024 EPS estimates for Cross Country Healthcare in a report issued on Monday, May 6th. Barrington Research analyst K. Steinke now expects that the business services provider will post earnings per share of $0.15 for the quarter, down from their prior estimate of $0.26. Barrington Research has a "Outperform" rating and a $21.00 price target on the stock. The consensus estimate for Cross Country Healthcare's current full-year earnings is $0.77 per share. Barrington Research also issued estimates for Cross Country Healthcare's Q4 2024 earnings at $0.21 EPS, FY2024 earnings at $0.70 EPS and FY2025 earnings at $1.07 EPS.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings data on Wednesday, May 1st. The business services provider reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. The firm had revenue of $379.17 million for the quarter, compared to the consensus estimate of $374.38 million. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.69%. The business's revenue for the quarter was down 39.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.84 earnings per share.
A number of other brokerages also recently issued reports on CCRN. Truist Financial reduced their price objective on shares of Cross Country Healthcare from $22.00 to $16.00 and set a "hold" rating on the stock in a research note on Thursday, February 22nd. Benchmark reduced their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set a "buy" rating on the stock in a research note on Thursday, May 2nd. Finally, TheStreet downgraded shares of Cross Country Healthcare from a "b-" rating to a "c+" rating in a research note on Friday, March 1st. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $20.83.
Check Out Our Latest Report on Cross Country Healthcare
Cross Country Healthcare Trading Down 0.4 %
Cross Country Healthcare stock traded down $0.06 during trading hours on Thursday, reaching $16.41. 307,294 shares of the stock were exchanged, compared to its average volume of 449,203. The company has a market cap of $570.64 million, a P/E ratio of 12.62, a price-to-earnings-growth ratio of 2.17 and a beta of 0.77. Cross Country Healthcare has a twelve month low of $15.65 and a twelve month high of $28.75. The stock has a 50 day moving average of $17.78 and a two-hundred day moving average of $19.86.
Hedge Funds Weigh In On Cross Country Healthcare
Hedge funds and other institutional investors have recently bought and sold shares of the company. SG Americas Securities LLC bought a new position in shares of Cross Country Healthcare in the 3rd quarter worth about $453,000. Raymond James & Associates bought a new position in shares of Cross Country Healthcare during the 3rd quarter worth approximately $2,097,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Cross Country Healthcare by 305.8% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,570 shares of the business services provider's stock worth $584,000 after buying an additional 17,762 shares during the period. TD Asset Management Inc increased its stake in shares of Cross Country Healthcare by 87.0% in the 3rd quarter. TD Asset Management Inc now owns 14,400 shares of the business services provider's stock valued at $357,000 after acquiring an additional 6,700 shares in the last quarter. Finally, Paradiem LLC lifted its position in shares of Cross Country Healthcare by 5.0% during the 3rd quarter. Paradiem LLC now owns 131,989 shares of the business services provider's stock valued at $3,272,000 after acquiring an additional 6,341 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.
Insider Activity
In other news, insider Karen Mote sold 6,216 shares of the firm's stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $16.95, for a total transaction of $105,361.20. Following the completion of the transaction, the insider now directly owns 35,101 shares in the company, valued at $594,961.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 4.90% of the company's stock.
Cross Country Healthcare Company Profile
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
